Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 4/20 | 0.48 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.48 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.48 |
| ▸ | PTGER1 | P34995 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16319477 | 0.86 | POLB (0.55) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL490691 | 0.85 | CTSG (0.56) | PTGER4PTGER3PTGER2PTGER1CTSG | |
| SCHEMBL23964581 | 0.85 | PTGER4 (0.60) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL27747620 | 0.83 | MEN1 (0.47) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL7293717 | 0.83 | KMT2A (0.49) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL17743633 | 0.83 | POLB (0.49) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL7885276 | 0.83 | CTSG (0.55) | PTGER4PTGER3PTGER2PTGER1CTSG | |
| SCHEMBL8408142 | 0.81 | GABRA1 (0.50) | NPSR1L3MBTL1 | |
| SCHEMBL7796396 | 0.81 | NR1H4 (0.47) | PTGER4PTGER3PTGER2PTGER1POLB | |
| SCHEMBL3408740 | 0.80 | KMT2A (0.54) | PTGER4PTGER3PTGER2PTGER1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7173139-B2 | Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2007-02-06 | — | — | US | disclosed |
| US-20030236438-A1 | Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236438-A1 | Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts | NAT1, AOX1, ALDH7A1 | PTGER4 1505/4885PTGER3 2259/4885PTGER2 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.